|
Volumn 13, Issue 3, 2001, Pages 129-134
|
Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults
|
Author keywords
Attention deficit disorder with hyperactivity; Bupropion; Methylphenidate
|
Indexed keywords
AMFEBUTAMONE;
METHYLPHENIDATE;
PLACEBO;
ADULT;
ARTICLE;
ATTENTION DEFICIT DISORDER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
HUMAN;
MALE;
NEUROPSYCHOLOGICAL TEST;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
RECALL;
SCORING SYSTEM;
STATISTICAL ANALYSIS;
SUSTAINED RELEASE PREPARATION;
TREATMENT OUTCOME;
VERBAL MEMORY;
ADRENERGIC AGENTS;
ADULT;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
BUPROPION;
DOPAMINE UPTAKE INHIBITORS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
METHYLPHENIDATE;
NEUROPSYCHOLOGICAL TESTS;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0035672864
PISSN: 10401237
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1012239823148 Document Type: Article |
Times cited : (100)
|
References (18)
|